Biotech Values

[kris_kade]

On a side note, it appears MNTA went offensive with their law suit which ostensibiliy helped prop up the PPS (which it did briefly) to ensure the offering can be made at higher price.

To be fair, CW did hint the possibility of financing FOB internally. From 3Q CC transcript:

We plan to expand and develop our follow-on biologics portfolio through collaborations as well as through our own investment. And I'm engaged in productive discussions with several companies, who are committed to applying our innovative technology to the FOB field.

NOw which one they see as more important...M118 or FOB..looks like the later.